Tag: nasdaq:crbp

January 17, 2020

Cannabis Weekly Round-Up: Analysts Encouraged by New Results

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
January 16, 2020

New Cannabis ETF Makes European Debut

Purpose Investments participated in the debut of the Medical Cannabis & Wellness UCITS ETF, which offers cannabis exposure to Europeans.
June 19, 2019

Cannabis ETFs — Should You Invest?

Cannabis stocks can be precarious, but what about cannabis ETFs? Here's a look at why investors may want to consider...
March 18, 2019

Investing in Cannabis Biotech Stocks

Investors have gained new options in the marijuana space thanks to the emergence of cannabis biotech stocks working on new...
July 25, 2018

Corbus Pharmaceuticals to Commence Phase 3 Study of Lenabasum for the Treatment of Rare Autoimmune Disease Dermatomyositis

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) has announced that it will proceed with a Phase 3 trial evaluating the efficacy and safety...
July 20, 2018

Corbus Pharmaceuticals Receives FDA Orphan Drug Designation for Lenabasum for the Treatment of Dermatomyositis

Corbus Pharmaceuticals (NASDAQ:CRBP) has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to...